SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031469
Filing Date
2024-08-13
Accepted
2024-08-13 08:15:44
Documents
73
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1157263
2 ex3-1.htm EX-3.1 35901
3 ex31-1.htm EX-31.1 21637
4 ex31-2.htm EX-31.2 21049
5 ex32-1.htm EX-32.1 8084
6 ex32-2.htm EX-32.2 8493
7 ex3-1_001.jpg GRAPHIC 32788
8 ex3-1_002.jpg GRAPHIC 84008
9 ex3-1_003.jpg GRAPHIC 111490
10 ex3-1_004.jpg GRAPHIC 95189
11 ex3-1_005.jpg GRAPHIC 97244
12 ex3-1_006.jpg GRAPHIC 120366
13 ex3-1_007.jpg GRAPHIC 97982
14 ex3-1_008.jpg GRAPHIC 112605
15 ex3-1_009.jpg GRAPHIC 44294
16 ex3-1_010.jpg GRAPHIC 15913
  Complete submission text file 0001493152-24-031469.txt   6028959

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE cing-20240630.xsd EX-101.SCH 36564
18 XBRL CALCULATION FILE cing-20240630_cal.xml EX-101.CAL 47667
19 XBRL DEFINITION FILE cing-20240630_def.xml EX-101.DEF 143333
20 XBRL LABEL FILE cing-20240630_lab.xml EX-101.LAB 264816
21 XBRL PRESENTATION FILE cing-20240630_pre.xml EX-101.PRE 211774
76 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 751527
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40874 | Film No.: 241198880
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)